<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="hsr270507" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Health Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Health Sci Rep</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2398-8835</journal-id><journal-id journal-id-type="publisher-id">HSR2</journal-id><journal-title-group><journal-title>Health Science Reports</journal-title></journal-title-group><issn pub-type="epub">2398-8835</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40008224</article-id><article-id pub-id-type="pmc">PMC11850194</article-id>
<article-id pub-id-type="doi">10.1002/hsr2.70507</article-id><article-id pub-id-type="publisher-id">HSR270507</article-id><article-categories><subj-group subj-group-type="article-subject-classification"><subject>Infectious Diseases</subject></subj-group><subj-group subj-group-type="article-subject-classification"><subject>Neurology</subject></subj-group><subj-group subj-group-type="article-subject-classification"><subject>Genetics and Genomics</subject></subj-group><subj-group subj-group-type="article-subject-classification"><subject>General Medicine</subject></subj-group><subj-group subj-group-type="article-subject-classification"><subject>Epidemiology</subject></subj-group><subj-group subj-group-type="article-subject-classification"><subject>Environmental Health</subject></subj-group><subj-group subj-group-type="article-subject-classification"><subject>Public Health</subject></subj-group><subj-group subj-group-type="overline"><subject>Original Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Health&#x02010;Related Quality of Life One Year After Intensive Care Unit Admission for COVID&#x02010;19: A Retrospective, Cross&#x02010;Sectional, Longitudinal Observational Study</article-title></title-group><contrib-group><contrib id="hsr270507-cr-0001" contrib-type="author"><name><surname>Samuelsson</surname><given-names>Carina M.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5611-9375</contrib-id><xref rid="hsr270507-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="hsr270507-cr-0002" contrib-type="author"><name><surname>Hussain</surname><given-names>Netha</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-5882-952X</contrib-id><xref rid="hsr270507-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="hsr270507-cr-0003" contrib-type="author"><name><surname>Drummond</surname><given-names>Avril</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-1220-8354</contrib-id><xref rid="hsr270507-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="hsr270507-cr-0004" contrib-type="author" corresp="yes"><name><surname>Persson</surname><given-names>Carina U.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9826-9483</contrib-id><xref rid="hsr270507-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="hsr270507-aff-0004" ref-type="aff">
<sup>4</sup>
</xref><xref rid="hsr270507-aff-0005" ref-type="aff">
<sup>5</sup>
</xref><address><email>carina.persson@neuro.gu.se</email></address></contrib></contrib-group><aff id="hsr270507-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Occupational Therapy and Physiotherapy</named-content>
<institution>Sahlgrenska University Hospital/&#x000d6;stra</institution>
<city>Gothenburg</city>
<country country="SE">Sweden</country>
</aff><aff id="hsr270507-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Radiology</named-content>
<institution>Sahlgrenska University Hospital</institution>
<city>Gothenburg</city>
<country country="SE">Sweden</country>
</aff><aff id="hsr270507-aff-0003">
<label>
<sup>3</sup>
</label>
<institution>Faculty of Medicine and Health Sciences, University of Nottingham</institution>
<city>Nottingham</city>
<country country="GB">UK</country>
</aff><aff id="hsr270507-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Clinical Neuroscience, Rehabilitation Medicine</named-content>
<institution>Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg</institution>
<city>Gothenburg</city>
<country country="SE">Sweden</country>
</aff><aff id="hsr270507-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Medicine, Geriatrics, and Emergency Medicine</named-content>
<institution>Centre for Lifestyle Intervention, Sahlgrenska University Hospital/&#x000d6;stra</institution>
<city>Gothenburg</city>
<country country="SE">Sweden</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence:</bold> Carina U. Persson (<email>carina.persson@neuro.gu.se</email>)<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>24</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>8</volume><issue seq="23">2</issue><issue-id pub-id-type="doi">10.1002/hsr2.v8.2</issue-id><elocation-id>e70507</elocation-id><history>
<date date-type="rev-recd"><day>15</day><month>1</month><year>2025</year></date>
<date date-type="received"><day>20</day><month>6</month><year>2024</year></date>
<date date-type="accepted"><day>23</day><month>1</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 The Author(s). Health Science Reports published by Wiley Periodicals LLC.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">Health Science Reports</italic> published by Wiley Periodicals LLC.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:HSR2-8-e70507.pdf"/><abstract><title>ABSTRACT</title><sec id="hsr270507-sec-0010"><title>Background and Aims</title><p>Although sequelae are commonly reported in intensive care unit (ICU) survivors following COVID&#x02010;19, country&#x02010;specific long&#x02010;term health&#x02010;related quality of life (HRQoL) studies are scarce. Therefore, the aims were to describe HRQoL and to identify early factors associated with impaired HRQoL 1 year after ICU admission following COVID&#x02010;19.</p></sec><sec id="hsr270507-sec-0020"><title>Methods</title><p>This retrospective, cross&#x02010;sectional, longitudinal observational study assessed HRQoL 1 year after ICU admission for COVID&#x02010;19 during the first wave of the pandemic. HRQoL was measured using the EuroQol 5 Dimensions 3 Levels (EQ&#x02010;5D&#x02010;3L) questionnaire, which covers Mobility, Self&#x02010;Care, Usual Activities, Pain/Discomfort and Anxiety/Depression, along with the EuroQol visual analogue scale (EQ&#x02010;VAS). Univariable and multivariable logistic regression analyses were performed to identify associations between HRQoL and the independent variables.</p></sec><sec id="hsr270507-sec-0030"><title>Results</title><p>A total of 105 participants (median age 58 [interquartile range {IQR}: 51&#x02013;66] years) completed the EQ&#x02010;5D&#x02010;3L. Over two&#x02010;thirds (<italic toggle="yes">n</italic>&#x02009;=&#x02009;73, 69%) reported moderate or extreme problems related to Pain/Discomfort and half (<italic toggle="yes">n</italic>&#x02009;=&#x02009;53, 51%) reported problems related to Anxiety/Depression. The mean EQ&#x02010;5D&#x02010;3L value index was 0.83 (standard deviation &#x000b1;0.13). For the EQ&#x02010;VAS (<italic toggle="yes">n</italic>&#x02009;=&#x02009;103), the median score was 70 (IQR: 59&#x02013;80). Diabetes mellitus was associated with impaired HRQoL in Self&#x02010;Care (odds ratio [OR]: 7.51, 95% confidence interval [CI]: 1.77&#x02013;31.92) and longer length of stay in ICU was associated with impaired HRQoL in both Usual Activities (OR: 1.03, 95% CI: 1.01&#x02013;1.05) and Pain/Discomfort (OR: 1.08, 95% CI: 1.03&#x02013;1.13). Also, younger age (OR: 0.96, 95% CI: 0.92&#x02013;1.00) and female sex (OR: 0.21, 95% CI: 0.06&#x02013;0.70) were associated with impaired HRQoL in Pain/Discomfort.</p></sec><sec id="hsr270507-sec-0040"><title>Conclusion</title><p>The prevalence of impaired HRQoL 1 year after ICU care due to COVID&#x02010;19 is a public health concern. Our findings imply that COVID&#x02010;19 ICU survivors, and particularly those with diabetes, should be followed up beyond 1 year to identify those in need of continued mental and physical health care and rehabilitation.</p></sec></abstract><kwd-group><kwd id="hsr270507-kwd-0001">COVID&#x02010;19</kwd><kwd id="hsr270507-kwd-0002">health&#x02010;related quality of life</kwd><kwd id="hsr270507-kwd-0003">health status</kwd><kwd id="hsr270507-kwd-0004">intensive care unit</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>This research was supported by The Swedish Government and the County Councils, the ALF agreement (ALFGBG&#x02010;881811).</funding-source></award-group></funding-group><counts><fig-count count="3"/><table-count count="3"/><page-count count="10"/><word-count count="6712"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>February 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:26.02.2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="background" id="hsr270507-sec-0050"><label>1</label><title>Background</title><p>From March 2020 until May 2023, coronavirus 2019 (COVID&#x02010;19) was classified as a pandemic [<xref rid="hsr270507-bib-0001" ref-type="bibr">1</xref>]. A large proportion of COVID&#x02010;survivors have been affected by long&#x02010;term sequelae, referred to as post&#x02010;COVID&#x02010;19 [<xref rid="hsr270507-bib-0002" ref-type="bibr">2</xref>]. In intensive care unit (ICU) survivors with COVID&#x02010;19, fatigue [<xref rid="hsr270507-bib-0003" ref-type="bibr">3</xref>, <xref rid="hsr270507-bib-0004" ref-type="bibr">4</xref>, <xref rid="hsr270507-bib-0005" ref-type="bibr">5</xref>], cognitive impairment [<xref rid="hsr270507-bib-0004" ref-type="bibr">4</xref>, <xref rid="hsr270507-bib-0005" ref-type="bibr">5</xref>], dyspnoea [<xref rid="hsr270507-bib-0006" ref-type="bibr">6</xref>, <xref rid="hsr270507-bib-0007" ref-type="bibr">7</xref>] and restricted exercise capacity [<xref rid="hsr270507-bib-0008" ref-type="bibr">8</xref>, <xref rid="hsr270507-bib-0009" ref-type="bibr">9</xref>] have all been reported in the year after admission. However, it is not clear what impact these symptoms have specifically on individuals' health&#x02010;related quality of life (HRQoL) [<xref rid="hsr270507-bib-0010" ref-type="bibr">10</xref>, <xref rid="hsr270507-bib-0011" ref-type="bibr">11</xref>]. There is also limited country&#x02010;specific data regarding the long&#x02010;term prevalence of impaired HRQoL at 1 year following ICU admission for COVID&#x02010;19 [<xref rid="hsr270507-bib-0004" ref-type="bibr">4</xref>, <xref rid="hsr270507-bib-0012" ref-type="bibr">12</xref>]. It is important to bridge this knowledge gap since there are already population variabilities between countries, as for example in population density, median age, land area and gross domestic product [<xref rid="hsr270507-bib-0013" ref-type="bibr">13</xref>].</p><p>Prior studies on HRQoL have largely focused on individuals with varying severity of COVID&#x02010;19 and with varying follow&#x02010;up times of up to 1 year [<xref rid="hsr270507-bib-0010" ref-type="bibr">10</xref>, <xref rid="hsr270507-bib-0014" ref-type="bibr">14</xref>, <xref rid="hsr270507-bib-0015" ref-type="bibr">15</xref>, <xref rid="hsr270507-bib-0016" ref-type="bibr">16</xref>, <xref rid="hsr270507-bib-0017" ref-type="bibr">17</xref>, <xref rid="hsr270507-bib-0018" ref-type="bibr">18</xref>, <xref rid="hsr270507-bib-0019" ref-type="bibr">19</xref>, <xref rid="hsr270507-bib-0020" ref-type="bibr">20</xref>]. There is sparse data exclusively on 1&#x02010;year follow&#x02010;up of patients with severe COVID&#x02010;19 admitted to an ICU [<xref rid="hsr270507-bib-0021" ref-type="bibr">21</xref>]. Several previous studies of COVID&#x02010;19 survivors have reported that approximately 50%&#x02013;60% had impaired HRQoL 1 year after ICU care [<xref rid="hsr270507-bib-0004" ref-type="bibr">4</xref>, <xref rid="hsr270507-bib-0005" ref-type="bibr">5</xref>, <xref rid="hsr270507-bib-0022" ref-type="bibr">22</xref>, <xref rid="hsr270507-bib-0023" ref-type="bibr">23</xref>, <xref rid="hsr270507-bib-0024" ref-type="bibr">24</xref>].</p><p>To enable identification of at&#x02010;risk individuals of impaired HRQoL already during the ICU care, it is important to identify the early predictors. However, research on risk factors for impaired HRQoL at 1 year after ICU care following severe COVID&#x02010;19 is scarce. Previous studies have shown that both male [<xref rid="hsr270507-bib-0022" ref-type="bibr">22</xref>] and female sex [<xref rid="hsr270507-bib-0012" ref-type="bibr">12</xref>, <xref rid="hsr270507-bib-0023" ref-type="bibr">23</xref>], and comorbidities [<xref rid="hsr270507-bib-0012" ref-type="bibr">12</xref>] have been identified as predictors. To the best of our knowledge, the predictors for specific factors affecting the dimensions of HRQoL related to the survey instrument EuroQol 5 Dimensions (EQ&#x02010;5D) [<xref rid="hsr270507-bib-0025" ref-type="bibr">25</xref>], i.e., Mobility, Self&#x02010;Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression, have not previously been investigated. This knowledge will be of value for primary healthcare practitioners and policy makers to facilitate early rehabilitation in addition to long&#x02010;term follow&#x02010;up and support for individuals at&#x02010;risk of impaired HRQoL.</p><p>Along the pandemic, the disease has changed [<xref rid="hsr270507-bib-0026" ref-type="bibr">26</xref>]. However, in the post&#x02010;COVID era where physicians face the long&#x02010;term consequences of the disease, it is clinically relevant and important to address these gaps related to the unavailability of country&#x02010;specific prevalence data and the limited number of prediction studies. The aims of this study therefore were to describe the HRQoL and to identify early factors associated with impaired HRQoL 1 year after ICU admission following severe COVID&#x02010;19. We hypothesized that impaired HRQoL was common 1 year after admission to ICU due to COVID&#x02010;19. Based on previous research, we hypothesized that older age [<xref rid="hsr270507-bib-0019" ref-type="bibr">19</xref>], male sex [<xref rid="hsr270507-bib-0022" ref-type="bibr">22</xref>], longer length of stay in ICU [<xref rid="hsr270507-bib-0019" ref-type="bibr">19</xref>] and comorbidities [<xref rid="hsr270507-bib-0027" ref-type="bibr">27</xref>] were associated with impaired HRQoL.</p></sec><sec sec-type="methods" id="hsr270507-sec-0060"><label>2</label><title>Methods</title><p>This study, the Gothenburg Recovery and Rehabilitation after COVID&#x02010;19 and Intensive Care Unit (GOT&#x02010;RECOV&#x02010;19 ICU), had a retrospective, cross&#x02010;sectional, and longitudinal observational design. The GOT&#x02010;RECOV&#x02010;19 ICU study was registered at &#x0201c;FoU i Sverige&#x0201d; (Research and development in Sweden, <ext-link xlink:href="http://researchweb.org" ext-link-type="uri">researchweb.org</ext-link>) on May 28, 2020 (ID number: 274477) and has three previous related publications [<xref rid="hsr270507-bib-0003" ref-type="bibr">3</xref>, <xref rid="hsr270507-bib-0028" ref-type="bibr">28</xref>, <xref rid="hsr270507-bib-0029" ref-type="bibr">29</xref>]. Ethical approval was obtained on September 24, 2020 (ID number 2020&#x02010;03264) from the Swedish Ethical Review Authority. An additional approval was obtained on June 29, 2021 (ID number 2021&#x02010;03220) for the sending of the remainder emails to participants. The study was conducted in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines [<xref rid="hsr270507-bib-0030" ref-type="bibr">30</xref>].</p><p>The inclusion criteria were individuals, 18 years of age or older, diagnosed with COVID&#x02010;19 (diagnostic code U07.1, according to the classification system ICD&#x02010;10) and who were still alive 1 year after admission to one of the five ICUs at Sahlgrenska University Hospital between March 1st to June 30th, 2020. The exclusion criteria were individuals not living in Gothenburg or its surrounding municipalities or not registered as a resident of Sweden in the Swedish Population Register. Individuals who met the inclusion criteria were sent a postal request to participate, including clinical assessments and questionnaires. At most, two postal reminders were sent to those who did not respond. In the second reminder, potential participants were given an option to respond only to the questionnaires. All participants gave written informed consent before their inclusion.</p><p>The clinical characteristics of the participants at baseline were obtained from medical records. The independent variables (i.e., potential predictors) were personal factors (i.e., age and sex), ICU diagnosis (i.e., acute respiratory distress syndrome (ARDS) and sepsis), comorbidities (i.e., diabetes mellitus and heart disease [chronic heart failure and coronary heart disease]) and clinical parameters (i.e., mechanical ventilation [intubation] and length of stay in ICU).</p><p>Starting in March 2021, data on the primary outcome, HRQoL, was collected consecutively 1 year after ICU admission due to COVID&#x02010;19. HRQoL was assessed using the EQ&#x02010;5D&#x02010;3L questionnaire, a standardized tool developed by the EuroQol Group to measure HRQoL [<xref rid="hsr270507-bib-0031" ref-type="bibr">31</xref>]. The questionnaire consists of two sections: the EQ&#x02010;5D&#x02010;3L descriptive system [<xref rid="hsr270507-bib-0025" ref-type="bibr">25</xref>] and the EQ&#x02010;5D&#x02010;3L visual analogue scale (EQ&#x02010;VAS) [<xref rid="hsr270507-bib-0025" ref-type="bibr">25</xref>]. The dependent variables were the five dimensions describing HRQoL in the EQ&#x02010;5D&#x02010;3L (i.e., Mobility, Self&#x02010;Care, Usual Activities, Pain/Discomfort, Anxiety/Depression). Each of the five dimensions has a statement with three response categories: no problems, moderate problems, and extreme problems, labeled level one to three, respectively. For each dimension, the participants chose the most appropriate statement regarding their present health status [<xref rid="hsr270507-bib-0032" ref-type="bibr">32</xref>]. A fully completed EQ&#x02010;5D&#x02010;3L, consisting of the five options, results in a unique health state represented by five digits. The health state 11111 indicates no problems in any of the five dimensions, while the health state 33333 indicates extreme problems in all the dimensions [<xref rid="hsr270507-bib-0032" ref-type="bibr">32</xref>]. The health state of each participant was then converted into the EQ&#x02010;5D&#x02010;3L value index, a score between 0 and 1 [<xref rid="hsr270507-bib-0033" ref-type="bibr">33</xref>]. The EQ&#x02010;5D&#x02010;3L value index was obtained by experience&#x02010;based value set, using reference data from 45,477 individuals of the Swedish general population [<xref rid="hsr270507-bib-0033" ref-type="bibr">33</xref>]. The participants were also asked to score their self&#x02010;perceived present health status using the EQ&#x02010;VAS. This is a vertical scale ranging from &#x0201c;The worst health you can imagine&#x0201d; (0) to &#x0201c;The best health you can imagine&#x0201d; (100) and is a valid and reliable questionnaire for describing and valuing health [<xref rid="hsr270507-bib-0025" ref-type="bibr">25</xref>]. It has been employed in prior COVID&#x02010;19 studies [<xref rid="hsr270507-bib-0019" ref-type="bibr">19</xref>, <xref rid="hsr270507-bib-0022" ref-type="bibr">22</xref>, <xref rid="hsr270507-bib-0023" ref-type="bibr">23</xref>, <xref rid="hsr270507-bib-0034" ref-type="bibr">34</xref>]. The EQ&#x02010;VAS has five severity levels from very poor to very good health, based on cohort data from the general Swedish population [<xref rid="hsr270507-bib-0033" ref-type="bibr">33</xref>].</p><sec id="hsr270507-sec-0070"><label>2.1</label><title>Statistics</title><p>Descriptive data on participant characteristics and data derived from the EQ&#x02010;5D&#x02010;3L and the EQ&#x02010;VAS were presented as means and standard deviations (SDs) or as medians and interquartile ranges (IQRs) for both interval and ordinal data. Nominal data was presented as frequencies (n) and percentages (%). The statistical analyses were performed using the IBM Statistical Package for Social Sciences (SPSS) software, version 28.</p><p>Mann&#x02013;Whitney <italic toggle="yes">U</italic>&#x02010;tests were performed to compare age, sex, and length of stay at ICU between two groups: the 105 individuals who participated in the study and those who declined participation or did not respond to the study request. Univariable logistic regression analyses were performed to identify any association between the five dependent variables, Mobility, Self&#x02010;Care, Usual Activities, Pain/Discomfort and Anxiety/Depression, in the EQ&#x02010;5D&#x02010;3L (one analysis for each dimension was conducted) and the independent variables. In the regression analyses, based on the answers in every dimension, the EQ&#x02010;5D&#x02010;3L results were dichotomized [<xref rid="hsr270507-bib-0032" ref-type="bibr">32</xref>] to &#x0201c;no problems&#x0201d; (Level 1) versus &#x0201c;any problems&#x0201d; [i.e., &#x0201c;moderate problems&#x0201d; (Level 2) or &#x0201c;extreme problems&#x0201d; (Level 3)] [<xref rid="hsr270507-bib-0025" ref-type="bibr">25</xref>]. To be included in the multivariable logistic regression analysis, a cut&#x02010;off value of <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.10 was applied in the univariable analyses, however, age and sex were included as confounders regardless of their <italic toggle="yes">p</italic>&#x02010;values.</p><p>Any multicollinearity between the independent variables was determined using Spearman's rank correlation, where a correlation coefficient &#x02265;&#x02009;0.7 were considered multicollinear [<xref rid="hsr270507-bib-0035" ref-type="bibr">35</xref>]. Model fit for the multivariable logistic regression was assessed with the Hosmer&#x02013;Lemeshow test, and improvements in model fit were evaluated using Cox &#x00026; Snell and Nagelkerke pseudo <italic toggle="yes">R</italic>
<sup>2</sup> values. The results of the univariable and multivariable logistic regression analyses were presented as odds ratios (ORs) with 95% confidence intervals (CIs). A <italic toggle="yes">p</italic>&#x02010;value &#x02264;&#x02009;0.05 (two&#x02010;tailed) was considered statistically significant in the final multivariable models.</p></sec></sec><sec sec-type="results" id="hsr270507-sec-0080"><label>3</label><title>Results</title><p>Of the 259 patients who were admitted to the relevant ICUs during the study period, 64 died within the year after admission. Of the 182 invited ICU survivors who met the inclusion criteria, 105 (58%) responded to the EQ&#x02010;5D questionnaire and were included in the study. Figure&#x000a0;<xref rid="hsr270507-fig-0001" ref-type="fig">1</xref> shows the inclusion process.</p><fig position="float" fig-type="Figure" id="hsr270507-fig-0001"><label>Figure 1</label><caption><p>Enrollment in the study.</p></caption><graphic xlink:href="HSR2-8-e70507-g001" position="anchor" id="jats-graphic-1"/></fig><p>Table&#x000a0;<xref rid="hsr270507-tbl-0001" ref-type="table">1</xref> presents the clinical characteristics of the 103 participants (two did not score their self&#x02010;perceived health status on the EQ&#x02010;VAS) 1 year after admission to the ICU, divided into four groups based on their EQ&#x02010;VAS score and severity levels of health status (i.e., worse than poor health, poor health, fair health, and good/very good health). The levels of health status are based on classification performed in previous research [<xref rid="hsr270507-bib-0033" ref-type="bibr">33</xref>]. More than four out of five participants required mechanical ventilation, i.e., intubation, and three individuals were treated with extracorporeal membrane oxygenation (ECMO) therapy. The median age based on 105 participants at baseline was 58 (IQR: 51&#x02013;66) years, nearly three&#x02010;quarters were younger than 65 years and 24% (<italic toggle="yes">n</italic>&#x02009;=&#x02009;25) were women. The demographic characteristics at baseline for all the participants (<italic toggle="yes">n</italic>&#x02009;=&#x02009;105) have previously been presented [<xref rid="hsr270507-bib-0003" ref-type="bibr">3</xref>]. The non&#x02010;participants had a median age of 57 (IQR: 46&#x02013;65) years, and 27% were women (not shown in table). In those who had an EQ&#x02010;VAS score between 20 and 41 (i.e., worse than poor severity health status), more than four out of five were younger than 65 years. In addition, they had a higher BMI, and all were affected with ARDS during their hospital stay and had a longer ICU stay compared with the participants who scored over 41. We found no significant difference between the 105 participants recruited into the study and the 77 individuals who did not respond or declined to participate, regarding age, sex, or length of stay at ICU.</p><table-wrap position="float" id="hsr270507-tbl-0001" content-type="Table"><label>Table 1</label><caption><p>Clinical characteristics at baseline for the 103<xref rid="hsr270507-tbl1-note-0003" ref-type="table-fn">
<sup>a</sup>
</xref> participants divided into four groups based on their EQ&#x02010;VAS score and severity levels of health status, from left to right: worse than poor health, poor health, fair health and good/very good health.</p></caption><table frame="hsides" rules="groups"><col align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">EQ&#x02010;VAS score 20&#x02013;41</th><th align="center" valign="bottom" rowspan="1" colspan="1">EQ&#x02010;VAS score 42&#x02013;65</th><th align="center" valign="bottom" rowspan="1" colspan="1">EQ&#x02010;VAS score 66&#x02013;83</th><th align="center" valign="bottom" rowspan="1" colspan="1">EQ&#x02010;VAS score 84&#x02013;100</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Clinical characteristics at baseline</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">n</italic>&#x02009;=&#x02009;13</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">n</italic>&#x02009;=&#x02009;30</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">n</italic>&#x02009;=&#x02009;38</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">n</italic>&#x02009;=&#x02009;22</th></tr></thead><tbody valign="top"><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Age (years)</td><td align="center" valign="top" rowspan="1" colspan="1">58 (50&#x02013;62)</td><td align="center" valign="top" rowspan="1" colspan="1">58 (52&#x02013;64)</td><td align="center" valign="top" rowspan="1" colspan="1">58 (49&#x02013;68)</td><td align="center" valign="top" rowspan="1" colspan="1">61 (51&#x02013;71)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Age under 65 years</td><td align="center" valign="top" rowspan="1" colspan="1">11 (84.6)</td><td align="center" valign="top" rowspan="1" colspan="1">24 (80.0)</td><td align="center" valign="top" rowspan="1" colspan="1">24 (63.2)</td><td align="center" valign="top" rowspan="1" colspan="1">13 (59.1)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Sex, male</td><td align="center" valign="top" rowspan="1" colspan="1">11 (84.6)</td><td align="center" valign="top" rowspan="1" colspan="1">19 (63.3)</td><td align="center" valign="top" rowspan="1" colspan="1">30 (78.9)</td><td align="center" valign="top" rowspan="1" colspan="1">20 (90.9)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">BMI, kg/m<sup>2</sup> (<italic toggle="yes">n</italic>&#x02009;=&#x02009;54)</td><td align="center" valign="top" rowspan="1" colspan="1">33.5 (27.2&#x02013;37.3)</td><td align="center" valign="top" rowspan="1" colspan="1">26.9 (23.4&#x02013;31.0)</td><td align="center" valign="top" rowspan="1" colspan="1">31.3 (28.3&#x02013;34.8)</td><td align="center" valign="top" rowspan="1" colspan="1">28.4 (22.2&#x02013;33.6)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">ICU length of stay</td><td align="center" valign="top" rowspan="1" colspan="1">24 (12&#x02013;32)</td><td align="center" valign="top" rowspan="1" colspan="1">16 (7&#x02013;24)</td><td align="center" valign="top" rowspan="1" colspan="1">15 (8&#x02013;29)</td><td align="center" valign="top" rowspan="1" colspan="1">11 (10&#x02013;21)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Hospital length of stay (<italic toggle="yes">n</italic>&#x02009;=&#x02009;102)</td><td align="center" valign="top" rowspan="1" colspan="1">43 (25&#x02013;63)</td><td align="center" valign="top" rowspan="1" colspan="1">23 (16&#x02013;49)</td><td align="center" valign="top" rowspan="1" colspan="1">24 (16&#x02013;46)</td><td align="center" valign="top" rowspan="1" colspan="1">24 (15&#x02013;34)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Employed full&#x02010;time at ICU&#x02010;admission</td><td align="center" valign="top" rowspan="1" colspan="1">9 (69.2)</td><td align="center" valign="top" rowspan="1" colspan="1">23 (76.7)</td><td align="center" valign="top" rowspan="1" colspan="1">31 (81.6)</td><td align="center" valign="top" rowspan="1" colspan="1">11 (50.0)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">ARDS</td><td align="center" valign="top" rowspan="1" colspan="1">13 (100.0)</td><td align="center" valign="top" rowspan="1" colspan="1">14 (46.7)</td><td align="center" valign="top" rowspan="1" colspan="1">18 (47.4)</td><td align="center" valign="top" rowspan="1" colspan="1">11 (50.0)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Sepsis</td><td align="center" valign="top" rowspan="1" colspan="1">7 (53.8)</td><td align="center" valign="top" rowspan="1" colspan="1">12 (40.0)</td><td align="center" valign="top" rowspan="1" colspan="1">23 (60.5)</td><td align="center" valign="top" rowspan="1" colspan="1">13 (59.1)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Type of respiratory support</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mechanical ventilation (i.e., intubated)</td><td align="center" valign="top" rowspan="1" colspan="1">13 (100.0)</td><td align="center" valign="top" rowspan="1" colspan="1">23 (76.7)</td><td align="center" valign="top" rowspan="1" colspan="1">30 (78.9)</td><td align="center" valign="top" rowspan="1" colspan="1">19 (86.4)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">High flow oxygen therapy</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0.0)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (16.7)</td><td align="center" valign="top" rowspan="1" colspan="1">7 (18.4)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (13.6)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mask or nasal cannula</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0.0)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (6.7)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (2.6)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0.0)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Comorbidities</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Asthma</td><td align="center" valign="top" rowspan="1" colspan="1">2 (15.4)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (13.3)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (2.6)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (4.5)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Chronic heart failure</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0.0)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (6.7)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (2.6)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (4.5)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Chronic kidney disease</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0.0)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (10.0)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (5.3)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (4.5)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Chronic obstructive pulmonary disease</td><td align="center" valign="top" rowspan="1" colspan="1">1 (7.7)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0.0)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0.0)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (4.5)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Coronary heart disease</td><td align="center" valign="top" rowspan="1" colspan="1">3 (23.1)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (26.7)</td><td align="center" valign="top" rowspan="1" colspan="1">13 (34.2)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (13.6)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Diabetes mellitus</td><td align="center" valign="top" rowspan="1" colspan="1">3 (23.1)</td><td align="center" valign="top" rowspan="1" colspan="1">10 (33.3)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (21.1)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (9.1)</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Hypertension</td><td align="center" valign="top" rowspan="1" colspan="1">4 (30.8)</td><td align="center" valign="top" rowspan="1" colspan="1">16 (53.3)</td><td align="center" valign="top" rowspan="1" colspan="1">17 (44.7)</td><td align="center" valign="top" rowspan="1" colspan="1">6 (27.3)</td></tr></tbody></table><table-wrap-foot><fn id="hsr270507-tbl1-note-0001"><p>
<italic toggle="yes">Note:</italic> Data are presented as medians (IQR), frequencies (n), and percentages (%). The four severity levels of health status related to the EQ&#x02010;VAS score are based on previous research [<xref rid="hsr270507-bib-0033" ref-type="bibr">33</xref>].</p></fn><fn id="hsr270507-tbl1-note-0002"><p>Abbreviations: ARDS, acute respiratory distress; BMI, body mass index; EQ&#x02010;VAS, EQ visual analogue scale; ICU, intensive care unit; IQR, interquartile range; SD, standard deviation.</p></fn><fn id="hsr270507-tbl1-note-0003"><label>a</label><p>Two participants did not score their self&#x02010;perceived present health status on the EQ&#x02010;VAS.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>A summary of the EQ&#x02010;5D&#x02010;3L data with the proportions (%) of the three levels (no problems, moderate problems, and extreme problems) for each of the five dimensions for the participants is presented in Figure&#x000a0;<xref rid="hsr270507-fig-0002" ref-type="fig">2</xref>. The most common health state, reported by 21 participants (20%), was 11111, which refers to no problems in any health dimension. The second most common health state, reported by 15 (14%), was 11121, i.e., moderate problems related to Pain/Discomfort. None reported the health state 33333, i.e., none reported extreme problems in all the five dimensions. The most frequently reported problems (i.e., moderate, and extreme problems) were reported in Pain/Discomfort by more than two&#x02010;thirds (<italic toggle="yes">n</italic>&#x02009;=&#x02009;73, 69%). More than half (<italic toggle="yes">n</italic>&#x02009;=&#x02009;53, 51%) reported problems in Anxiety/Depression. One out of 10 participants reported problems related to Self&#x02010;Care and more than one&#x02010;third (<italic toggle="yes">n</italic>&#x02009;=&#x02009;37, 35% and <italic toggle="yes">n</italic>&#x02009;=&#x02009;42, 40%, respectively) reported problems related to Usual Activities and Mobility. Extreme problems were most prevalent in Pain/Discomfort and Anxiety/Depression, which were reported by 12 (11%) and 7 (7%) participants, respectively. Sixty&#x02010;four (61%) reported moderate or extreme problems in more than one dimension.</p><fig position="float" fig-type="Figure" id="hsr270507-fig-0002"><label>Figure 2</label><caption><p>Self&#x02010;perceived health status of the 105 participants using the EuroQol 5 Dimensions 3 Levels (EQ&#x02010;5D&#x02010;3L) 1 year following intensive care unit admission. The data is presented as the proportions (%) of the participants reporting no problems, moderate problems, extreme problems across the five dimensions.</p></caption><graphic xlink:href="HSR2-8-e70507-g002" position="anchor" id="jats-graphic-3"/></fig><p>The mean and the median of the EQ&#x02010;5D&#x02010;3L value index was 0.83 (SD 0.13) and 0.87 (IQR: 0.71&#x02013;0.93), respectively. For women and men, the mean value index was 0.84 (0.14) and 0.82 (0.13), respectively (not shown in table). Figure&#x000a0;<xref rid="hsr270507-fig-0003" ref-type="fig">3</xref> shows a compilation of the scores for the self&#x02010;perceived present health status according to the EQ&#x02010;VAS for the 103 participants who completed the EQ&#x02010;VAS scale. The median EQ&#x02010;VAS score was 70 (IQR: 59&#x02013;80) out of 100, which lies just above the level for a fair health status. For women and men, the median EQ&#x02010;VAS score was 60 (IQR: 50&#x02013;80) and 70 (IQR: 60&#x02013;84), respectively. The mean EQ&#x02010;VAS score was 67.6 (SD 19.2). Just over 1 in 10 (12%) participants had a health status worse than poor, while approximately one out of five (21%) had a health status of good or very good. Table&#x000a0;<xref rid="hsr270507-tbl-0002" ref-type="table">2</xref> shows the results from the univariable logistic regression analyses for each of the five dependent variables. Diabetes mellitus was identified as a significant predictor of increased problems related to Self&#x02010;Care, and longer length of stay in ICU as a predictor of problems related to Usual Activities and Pain/Discomfort. Between the other two HRQoL&#x02010;dimensions, Mobility and Anxiety/Depression, and the independent variables, no statistically significant association were found. The multivariable regression analysis showed that diabetes mellitus [OR: 7.51 (95% CI: 1.77&#x02013;31.92)], serves as a statistically significant predictor of impaired HRQoL in Self&#x02010;Care. Furthermore, in examining length of stay in the ICU as an independent variable, with Usual Activities and Pain/Discomfort as dependent variables, length of stay in ICU [OR: 1.03 (95% CI: 1.01&#x02013;1.05), and 1.08 (95% CI: 1.03&#x02013;1.13), respectively], was a statistically significant predictor for both outcomes. Additionally, younger age [OR: 0.96 (95% CI: 0.92&#x02013;1.00)], and female sex [OR: 0.21 (95% CI: 0.06&#x02013;0.70)], emerged as statistically significant predictors of impaired HRQoL in Pain/Discomfort in the multivariable regression analysis (shown in Table&#x000a0;<xref rid="hsr270507-tbl-0003" ref-type="table">3</xref>).</p><fig position="float" fig-type="Figure" id="hsr270507-fig-0003"><label>Figure 3</label><caption><p>Self&#x02010;perceived present health status of the 103 COVID&#x02010;19 survivors with a completed EuroQol visual analogue scale 1 year following intensive care unit admission.</p></caption><graphic xlink:href="HSR2-8-e70507-g003" position="anchor" id="jats-graphic-5"/></fig><table-wrap position="float" id="hsr270507-tbl-0002" content-type="Table"><label>Table 2</label><caption><p>Univariable logistic regression analyses, one for each of the five dependent variables, for early prediction of impaired HRQoL 1 year following admission to ICU due to COVID&#x02010;19 using the EQ&#x02010;5D&#x02010;3L for the 105 participants.</p></caption><table frame="hsides" rules="groups"><col align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">Mobility</th><th align="center" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">Self&#x02010;care</th><th align="center" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">Usual activities</th><th align="center" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">Pain/discomfort</th><th align="center" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">Anxiety/depression</th><th align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1">Independent variables</th><th align="center" valign="bottom" rowspan="1" colspan="1">Odds ratio (95% CI)</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">Odds ratio (95% CI)</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">Odds ratio (95% CI)</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">Odds ratio (95% CI)</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">Odds ratio (95% CI)</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Age<xref rid="hsr270507-tbl2-note-0003" ref-type="table-fn">a</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">1.01 (0.98&#x02013;1.05)</td><td align="center" valign="top" rowspan="1" colspan="1">0.56</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (0.94&#x02013;1.05)</td><td align="center" valign="top" rowspan="1" colspan="1">0.90</td><td align="center" valign="top" rowspan="1" colspan="1">0.98 (0.95&#x02013;1.02)</td><td align="center" valign="top" rowspan="1" colspan="1">0.27</td><td align="center" valign="top" rowspan="1" colspan="1">0.97 (0.94&#x02013;1.01)</td><td align="center" valign="top" rowspan="1" colspan="1">0.16</td><td align="center" valign="top" rowspan="1" colspan="1">0.97 (0.94&#x02013;1.00)</td><td align="center" valign="top" rowspan="1" colspan="1">0.07</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Male sex (Ref&#x02009;=&#x02009;female sex)</td><td align="center" valign="top" rowspan="1" colspan="1">0.61 (0.26&#x02013;1.61)</td><td align="center" valign="top" rowspan="1" colspan="1">0.35</td><td align="center" valign="top" rowspan="1" colspan="1">0.43 (0.11&#x02013;1.65)</td><td align="center" valign="top" rowspan="1" colspan="1">0.22</td><td align="center" valign="top" rowspan="1" colspan="1">0.76 (0.30&#x02013;1.93)</td><td align="center" valign="top" rowspan="1" colspan="1">0.57</td><td align="center" valign="top" rowspan="1" colspan="1">0.49 (0.17&#x02013;1.45)</td><td align="center" valign="top" rowspan="1" colspan="1">0.20</td><td align="center" valign="top" rowspan="1" colspan="1">0.48 (0.19&#x02013;1.22)</td><td align="center" valign="top" rowspan="1" colspan="1">0.13</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ARDS (Ref&#x02009;=&#x02009;No)</td><td align="center" valign="top" rowspan="1" colspan="1">0.80 (0.37&#x02013;1.75)</td><td align="center" valign="top" rowspan="1" colspan="1">0.58</td><td align="center" valign="top" rowspan="1" colspan="1">0.58 (0.15&#x02013;2.17)</td><td align="center" valign="top" rowspan="1" colspan="1">0.41</td><td align="center" valign="top" rowspan="1" colspan="1">1.24 (0.55&#x02013;2.77)</td><td align="center" valign="top" rowspan="1" colspan="1">0.60</td><td align="center" valign="top" rowspan="1" colspan="1">1.74 (0.75&#x02013;4.03)</td><td align="center" valign="top" rowspan="1" colspan="1">0.20</td><td align="center" valign="top" rowspan="1" colspan="1">1.30 (0.61&#x02013;2.81)</td><td align="center" valign="top" rowspan="1" colspan="1">0.50</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sepsis (Ref&#x02009;=&#x02009;No)</td><td align="center" valign="top" rowspan="1" colspan="1">0.73 (0.33&#x02013;1.59)</td><td align="center" valign="top" rowspan="1" colspan="1">0.43</td><td align="center" valign="top" rowspan="1" colspan="1">0.58 (0.15&#x02013;2.17)</td><td align="center" valign="top" rowspan="1" colspan="1">0.41</td><td align="center" valign="top" rowspan="1" colspan="1">1.56 (0.69&#x02013;3.50)</td><td align="center" valign="top" rowspan="1" colspan="1">0.29</td><td align="center" valign="top" rowspan="1" colspan="1">1.15 (0.50&#x02013;2.64)</td><td align="center" valign="top" rowspan="1" colspan="1">0.75</td><td align="center" valign="top" rowspan="1" colspan="1">1.04 (0.48&#x02013;2.23)</td><td align="center" valign="top" rowspan="1" colspan="1">0.93</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Diabetes mellitus (Ref&#x02009;=&#x02009;No)</td><td align="center" valign="top" rowspan="1" colspan="1">1.89 (0.77&#x02013;4.81)</td><td align="center" valign="top" rowspan="1" colspan="1">0.18</td><td align="center" valign="top" rowspan="1" colspan="1">6.88 (1.75&#x02013;27.07)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.006</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">1.24 (0.48&#x02013;3.20)</td><td align="center" valign="top" rowspan="1" colspan="1">0.66</td><td align="center" valign="top" rowspan="1" colspan="1">1.77 (0.59&#x02013;5.27)</td><td align="center" valign="top" rowspan="1" colspan="1">0.31</td><td align="center" valign="top" rowspan="1" colspan="1">0.87 (0.35&#x02013;2.20)</td><td align="center" valign="top" rowspan="1" colspan="1">0.77</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Heart disease (Ref&#x02009;=&#x02009;No)</td><td align="center" valign="top" rowspan="1" colspan="1">1.04 (0.43&#x02013;2.54)</td><td align="center" valign="top" rowspan="1" colspan="1">0.93</td><td align="center" valign="top" rowspan="1" colspan="1">0.30 (0.04&#x02013;2.44)</td><td align="center" valign="top" rowspan="1" colspan="1">0.26</td><td align="center" valign="top" rowspan="1" colspan="1">0.89 (0.35&#x02013;2.25)</td><td align="center" valign="top" rowspan="1" colspan="1">0.81</td><td align="center" valign="top" rowspan="1" colspan="1">0.54 (0.21&#x02013;1.34)</td><td align="center" valign="top" rowspan="1" colspan="1">0.18</td><td align="center" valign="top" rowspan="1" colspan="1">0.47 (0.30&#x02013;1.74)</td><td align="center" valign="top" rowspan="1" colspan="1">0.47</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mechanical ventilation (Ref&#x02009;=&#x02009;No)</td><td align="center" valign="top" rowspan="1" colspan="1">0.78 (0.29&#x02013;2.07)</td><td align="center" valign="top" rowspan="1" colspan="1">0.78</td><td align="center" valign="top" rowspan="1" colspan="1">1.35 (0.36&#x02013;5.09)</td><td align="center" valign="top" rowspan="1" colspan="1">0.66</td><td align="center" valign="top" rowspan="1" colspan="1">1.81 (0.60&#x02013;5.46)</td><td align="center" valign="top" rowspan="1" colspan="1">0.29</td><td align="center" valign="top" rowspan="1" colspan="1">2.21 (0.81&#x02013;6.01)</td><td align="center" valign="top" rowspan="1" colspan="1">0.12</td><td align="center" valign="top" rowspan="1" colspan="1">1.31 (0.49&#x02013;3.49)</td><td align="center" valign="top" rowspan="1" colspan="1">0.59</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Length of stay in ICU<xref rid="hsr270507-tbl2-note-0003" ref-type="table-fn">a</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">1.02 (0.99&#x02013;1.04)</td><td align="center" valign="top" rowspan="1" colspan="1">0.07</td><td align="center" valign="top" rowspan="1" colspan="1">0.98 (0.94&#x02013;1.03)</td><td align="center" valign="top" rowspan="1" colspan="1">0.48</td><td align="center" valign="top" rowspan="1" colspan="1">1.02 (1.00&#x02013;1.04)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.04</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">1.05 (1.01&#x02013;1.09)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.02</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (0.09&#x02013;1.02)</td><td align="center" valign="top" rowspan="1" colspan="1">0.92</td></tr></tbody></table><table-wrap-foot><fn id="hsr270507-tbl2-note-0001"><p>
<italic toggle="yes">Note:</italic> The five dependent variables (Mobility, Self&#x02010;Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression) were dichotomized according to &#x0201c;no problems&#x0201d; versus &#x0201c;any problems&#x0201d; (i.e., moderate, or extreme problems). Significant values are given in <bold>bold</bold>.</p></fn><fn id="hsr270507-tbl2-note-0002"><p>Abbreviations: ARDS, acute respiratory distress syndrome; CI, confidence interval; EQ&#x02010;5D&#x02010;3L, EuroQol 5 Dimensions 3 Levels; HRQoL, health&#x02010;related quality of life; ICU, intensive care unit; <italic toggle="yes">p</italic>, <italic toggle="yes">p</italic>&#x02010;value.</p></fn><fn id="hsr270507-tbl2-note-0003"><label>a</label><p>Risk by one unit increase.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><table-wrap position="float" id="hsr270507-tbl-0003" content-type="Table"><label>Table 3</label><caption><p>Multivariable regression analysis predicting impaired HRQoL in self&#x02010;care, usual activities, and pain/discomfort 1&#x02010;year post&#x02010;ICU admission for COVID&#x02010;19, adjusted for age and sex (<italic toggle="yes">n</italic>&#x02009;=&#x02009;105).</p></caption><table frame="hsides" rules="groups"><col align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" colspan="3" valign="bottom" rowspan="1">Dependent variable&#x02014;Self&#x02010;care</th></tr><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1">Independent variables</th><th align="center" valign="bottom" rowspan="1" colspan="1">Odds ratio (95% CI)</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Age<xref rid="hsr270507-tbl3-note-0003" ref-type="table-fn">a</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.98 (0.92&#x02013;1.04)</td><td align="center" valign="top" rowspan="1" colspan="1">0.46</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sex (Ref&#x02009;=&#x02009;female sex)</td><td align="center" valign="top" rowspan="1" colspan="1">0.46 (0.11&#x02013;1.96)</td><td align="center" valign="top" rowspan="1" colspan="1">0.30</td></tr><tr style="border-bottom:solid 1px #000000"><td align="left" valign="top" rowspan="1" colspan="1">Diabetes mellitus</td><td align="center" valign="top" rowspan="1" colspan="1">7.51 (1.77&#x02013;31.92)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.006</bold>
</td></tr></tbody></table><table frame="hsides" rules="groups"><col align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" colspan="3" valign="bottom" rowspan="1">Dependent variable&#x02014;Usual activities</th></tr><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1">Independent variables</th><th align="center" valign="bottom" rowspan="1" colspan="1">Odds ratio (95% CI)</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Age<xref rid="hsr270507-tbl3-note-0003" ref-type="table-fn">a</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.97 (0.94&#x02013;1.01)</td><td align="center" valign="top" rowspan="1" colspan="1">0.14</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sex (Ref&#x02009;=&#x02009;female sex)</td><td align="center" valign="top" rowspan="1" colspan="1">0.49 (0.18&#x02013;1.33)</td><td align="center" valign="top" rowspan="1" colspan="1">0.16</td></tr><tr style="border-bottom:solid 1px #000000"><td align="left" valign="top" rowspan="1" colspan="1">Length of stay in ICU<xref rid="hsr270507-tbl3-note-0003" ref-type="table-fn">a</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">1.03 (1.01&#x02013;1.05)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.02</bold>
</td></tr></tbody></table><table frame="hsides" rules="groups"><col align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" colspan="3" valign="bottom" rowspan="1">Dependent variable&#x02014;Pain/discomfort</th></tr><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1">Independent variables</th><th align="center" valign="bottom" rowspan="1" colspan="1">Odds ratio (95% CI)</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Age<xref rid="hsr270507-tbl3-note-0003" ref-type="table-fn">a</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.96 (0.92&#x02013;1.00)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.05</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sex (Ref&#x02009;=&#x02009;female sex)</td><td align="center" valign="top" rowspan="1" colspan="1">0.21 (0.06&#x02013;0.70)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.01</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Length of stay in ICU<xref rid="hsr270507-tbl3-note-0003" ref-type="table-fn">a</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">1.08 (1.03&#x02013;1.13)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.002</bold>
</td></tr></tbody></table><table-wrap-foot><fn id="hsr270507-tbl3-note-0001"><p>
<italic toggle="yes">Note:</italic> For the models with the dependent variables self&#x02010;care, usual activities, and pain/discomfort, respectively: The Hosmer&#x02013;Lemeshow goodness&#x02010;of&#x02010;fit test yielded significance levels of 0.483, 0.899, and 0.642. The Cox &#x00026; Snell <italic toggle="yes">R</italic>
<sup>2</sup> values were 0.084, 0.079, and 0.170, and the Nagelkerke <italic toggle="yes">R</italic>
<sup>2</sup> values were 0.180, 0.109, and 0.240, respectively. The dependent variables (self&#x02010;care, usual activities and pain/discomfort) were dichotomized according to &#x0201c;no problems&#x0201d; versus &#x0201c;any problems&#x0201d; (i.e., moderate, or extreme problems). Significant values are given in <bold>bold</bold>.</p></fn><fn id="hsr270507-tbl3-note-0002"><p>Abbreviations: CI, confidence interval; EQ&#x02010;5D&#x02010;3L, EuroQol 5 Dimensions 3 Levels; HRQoL, health&#x02010;related quality of life; ICU, intensive care unit; <italic toggle="yes">p</italic>, <italic toggle="yes">p</italic>&#x02010;value.</p></fn><fn id="hsr270507-tbl3-note-0003"><label>
<sup>a</sup>
</label><p>Risk by one unit increase.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec sec-type="discussion" id="hsr270507-sec-0090"><label>4</label><title>Discussion</title><p>We aimed to describe HRQoL, and to identify any factors that were associated with impaired HRQoL, 1 year after ICU admission following severe COVID&#x02010;19. Using the EQ&#x02010;5D&#x02010;3L, we found that more than two&#x02010;thirds of the participants reported moderate or extreme problems related to Pain/Discomfort and that half reported problems related to anxiety/depression. Our hypothesis, that longer length of stay in ICU and comorbidities (here as the presence of diabetes mellitus) were predictors of impaired HRQoL 1 year after ICU admission, was confirmed. However, our hypothesis that older age, male sex, and other comorbidities were predictors of impaired HRQoL was rejected.</p><p>The mean EQ&#x02010;5D&#x02010;3L value index of 0.83 in the current study was lower than the mean value index of 0.91 reported in the general Swedish population [<xref rid="hsr270507-bib-0033" ref-type="bibr">33</xref>]. However, this is unsurprising considering that the participants in this study were affected by a severe disease requiring ICU treatment. Our median EQ&#x02010;5D&#x02010;3L value index of 0.87 were also lower than that of a prior study that reported a median value index of 0.91 [<xref rid="hsr270507-bib-0022" ref-type="bibr">22</xref>]; here the differences could be attributed to the inpatient rehabilitation received by the participants of that study.</p><p>The most reported problems in our study were related to pain/discomfort and anxiety/depression, which is consistent with the findings from three other studies 1 year following COVID&#x02010;19 and ICU care [<xref rid="hsr270507-bib-0021" ref-type="bibr">21</xref>, <xref rid="hsr270507-bib-0022" ref-type="bibr">22</xref>, <xref rid="hsr270507-bib-0023" ref-type="bibr">23</xref>]. Furthermore, more than one&#x02010;third of the participants in the current study reported problems related to Mobility and Usual Activities, which were higher than reported in a previous study [<xref rid="hsr270507-bib-0022" ref-type="bibr">22</xref>]; here all the participants received inpatient rehabilitation after ICU care, which may explain the difference. In Self&#x02010;Care, every tenth participant experienced problems 1 year after COVID&#x02010;19 following ICU care, again consistent with prior research where 13% [<xref rid="hsr270507-bib-0019" ref-type="bibr">19</xref>] and 9% [<xref rid="hsr270507-bib-0023" ref-type="bibr">23</xref>] of study participants at 6 and 12 months after severe COVID&#x02010;19, respectively, experienced problems. However, this is lower than the previously reported 21% in another study 1 year after COVID&#x02010;19 following ICU care [<xref rid="hsr270507-bib-0022" ref-type="bibr">22</xref>]. Due to the considerable prevalence of impaired long&#x02010;term HRQoL after ICU admission for COVID&#x02010;19, we suggest that long&#x02010;term individualized rehabilitation plans are required to support these individuals&#x02019; recovery.</p><p>The mean EQ&#x02010;VAS score of 67.6, interpreted as fair health [<xref rid="hsr270507-bib-0033" ref-type="bibr">33</xref>], from our study was unsurprisingly lower compared to the mean score of 79.5 in the Swedish general population [<xref rid="hsr270507-bib-0033" ref-type="bibr">33</xref>]. When comparing with previous research, also on first wave COVID&#x02010;19 ICU survivors, our EQ&#x02010;5D&#x02010;3L VAS scores were similar (67.6 vs. 68) [<xref rid="hsr270507-bib-0021" ref-type="bibr">21</xref>]. Our EQ&#x02010;VAS median score of 70, though, was in line with two prior studies of COVID&#x02010;19, which also reported 70 as median score for the survivors 1 year after discharge from ICU [<xref rid="hsr270507-bib-0022" ref-type="bibr">22</xref>, <xref rid="hsr270507-bib-0023" ref-type="bibr">23</xref>]. However, our EQ&#x02010;VAS median score was lower than a prior Swedish study's EQ&#x02010;VAS median score of 75, where the participants had a shorter ICU stay, which could indicate they had less severe COVID&#x02010;19 [<xref rid="hsr270507-bib-0036" ref-type="bibr">36</xref>]. Interestingly, according to both the EQ&#x02010;5D&#x02010;3L and the EQ&#x02010;VAS, the HRQoL for the participants in our study was the same (a median EQ&#x02010;5D&#x02010;3L value index of 0.87 and a median EQ&#x02010;VAS score of 70) as in a Swedish 5&#x02010;year follow up in stroke survivors, although they had a substantially higher mean age of approximately 76 years [<xref rid="hsr270507-bib-0037" ref-type="bibr">37</xref>]. Longer ICU stay has previously been shown to be a factor associated with impaired HRQoL 6 months after COVID&#x02010;19 following ICU care [<xref rid="hsr270507-bib-0019" ref-type="bibr">19</xref>], which is consistent with the findings from the current study. Also, in the present study, longer ICU stay was found to be a significant predictor of problems related to usual activities and pain/discomfort. As previously stated, longer ICU stay was a highly probable proxy for a more severe degree of disease [<xref rid="hsr270507-bib-0036" ref-type="bibr">36</xref>] which may explain these participants&#x02019; self&#x02010;perceived impaired HRQoL. Prior research has shown that self&#x02010;perceived HRQoL 3 months after ICU discharge, assessed using the EQ&#x02010;5D&#x02010;3L, was comparable between COVID&#x02010;19 survivors and non&#x02010;COVID&#x02010;19 survivors who had other critical illness, despite the longer ICU stay observed in the COVID&#x02010;19 group [<xref rid="hsr270507-bib-0038" ref-type="bibr">38</xref>]. In addition, diabetes mellitus was found to be a significant predictor of increased problems related to Self&#x02010;Care at 1 year following COVID&#x02010;19. Individuals with diabetes mellitus may have complications such as reduced sensation in the lower extremity, impaired vision, and cardiovascular diseases [<xref rid="hsr270507-bib-0039" ref-type="bibr">39</xref>, <xref rid="hsr270507-bib-0040" ref-type="bibr">40</xref>, <xref rid="hsr270507-bib-0041" ref-type="bibr">41</xref>], which may hinder their ability to self&#x02010;care and consequently lead to impaired HRQoL. In the present study, advanced age and male sex were identified as protective factors associated with Pain/Discomfort. This finding may be, albeit speculatively, attributed to the possibility that older individuals may have greater experience of pain and may employ different coping strategies to manage it and to that there may be sex&#x02010;related differences stemming from sociocultural and psychological factors, health conditions and disease patterns, supportive social networks and roles, as well as biological factors (e.g., hormonal influences). It is also likely that the large proportion of men (74.2%) in our study, influenced the outcome. Albeit using different assessment tools, there are similarities with a previous study of first wave COVID&#x02010;19 ICU survivors, showing female sex as a risk factor of impaired HRQoL [<xref rid="hsr270507-bib-0024" ref-type="bibr">24</xref>].</p><p>The strengths of the current study lie in its consecutive inclusion, the well&#x02010;defined population from a large geographical area of Sweden and the long follow&#x02010;up period. The findings could be generalized to individuals cared for at an ICU for COVID&#x02010;19 during the first wave of the pandemic in Sweden and adds to the existing literature by providing country&#x02010;specific data on the long&#x02010;term prevalence of impaired HRQoL. However, there are several limitations to consider. The sample size was relatively small, which resulted in a limitation of the number of the included potential factors associated with impaired HRQoL. The results can only be generalized to these predictors quantified using the EQ&#x02010;5D&#x02010;3L. Furthermore, the five dimensions in EQ&#x02010;5D&#x02010;3L do not cover the whole range of HRQoL. The sample size increases the likelihood that true effects in subgroup analyses may be missed, even if they exist. There is also a risk that positive results may be found by chance when no true effect is present. Due to the sudden onset of the pandemic, data regarding the participants&#x02019; pre&#x02010;admission HRQoL were not available. To avoid recall bias, we chose not to collect this data retrospectively. Consequently, we are unable to ascertain how the participants&#x02019; HRQoL have been affected by either COVID&#x02010;19, their stay in the ICU or both. However, it is also possible that HRQoL remained unchanged compared to the pre&#x02010;COVID period. Moreover, we acknowledge that the observational nature of our study limits the ability to draw causal inferences from the outcomes. Several events may have had an impact on the participant's HRQoL in the year following their ICU admission. The participants&#x02019; HRQoL may have been affected by the rate of rehabilitation after ICU care, and we do not have any valid data of any intervention after discharge from the ICU. The moderate response rate (58%) may have influenced the results. However, we did not find any significant differences in the baseline characteristics of age, sex, or length of stay at ICU between the participants and the non&#x02010;participants, which is why we believe our results are likely to be representative and unbiased for this population. However, healthier individuals may have been overrepresented in the study due to the higher likelihood of them participating. Conversely, it is also possible that individuals with more severe health issues were more motivated to participate, given the study's focus on health impairments. This potential response bias should be considered when interpreting the results, as it may influence the generalizability of our findings. Another potential limitation is that some important variables that could have been associated with impaired HRQoL were not included. Higher BMI, for example, has previously been shown to be a predictor of impaired HRQoL after COVID&#x02010;19 [<xref rid="hsr270507-bib-0042" ref-type="bibr">42</xref>]. Due to a substantial proportion of missing data, we were unable to analyse the BMI data in the current study. The absence of complete BMI data is a key limitation of this study, particularly in assessing its role as a predictor of HRQoL outcomes. Due to the extent of missing data, we did not use imputation methods to avoid potential biases (confounding and selection). As a result, the exclusion of BMI may limit the study's conclusions and introduce bias. Further studies with complete BMI data are needed to better evaluate its impact. Unfortunately, we did not have available data on other variables that may also influence HRQoL outcomes, such as socioeconomic status and mental health history.</p><p>We found that the greatest proportion of problems reported were related to pain/discomfort and anxiety/depression. Despite the large proportion of reported problems related to anxiety/depression, we did not find any predictors of this dimension. Further research with other potential predictors should have been merited, but is not possible more than more broadly, in terms of, for example, COVID&#x02010;19 vaccination. Furthermore, further research with a larger sample size and longer follow&#x02010;up time is recommended to determine whether HRQoL remains impaired or improves over time for individuals with severe COVID&#x02010;19 following ICU treatment. Similarly, the impact of BMI, socioeconomic status, and post&#x02010;ICU rehabilitation programs on HRQoL recovery after COVID&#x02010;19, for example, are other factors that could be of interest for future research.</p></sec><sec sec-type="conclusions" id="hsr270507-sec-0100"><label>5</label><title>Conclusion</title><p>Impaired HRQoL is common 1 year after COVID&#x02010;19 following ICU care. In this follow up, more than two&#x02010;thirds reported problems related to pain/discomfort and half reported problems related to anxiety/depression. Diabetes mellitus, longer stay in ICU, younger age and female sex were factors associated with impaired HRQoL. The significant long&#x02010;term prevalence of impaired HRQoL among individuals 1 year following ICU care due to COVID&#x02010;19 is a public health concern. Our findings imply that individuals who recovered after ICU admission for COVID&#x02010;19, and particularly those with diabetes mellitus, should be followed up beyond 1 year to identify those in need of mental and/or physical health care and rehabilitation. To support and enhance the recovery and HRQoL of COVID&#x02010;19 ICU survivors, the establishment of follow&#x02010;up clinics with multidisciplinary teams and the development of individualized care and rehabilitation plans seems worthy of serious consideration.</p></sec><sec id="hsr270507-sec-0110"><title>Author Contributions</title><p>All the authors made substantial contributions to the concept. C.M.S. and C.U.P. performed the data collection, including the clinical examinations. C.M.S. drafted the manuscript. C.UP., N.H., and A.D. revised the manuscript critically. N.H. and C.U.P. performed the data analysis. C.U.P., the principal investigator of the GOT&#x02010;RECOV&#x02010;19&#x02010;ICU&#x02010;study, was responsible for the management of the data and takes complete responsibility for the integrity of the data and the accuracy of the data analysis. All authors read and approved the final version of the manuscript.</p></sec><sec id="hsr270507-sec-0130"><title>Ethics Statement</title><p>This study was approved by the Swedish Ethical Review Authority (ID numbers: 2020&#x02010;03264 and 2021&#x02010;03220).</p></sec><sec id="hsr270507-sec-0140"><title>Consent</title><p>Written informed consent was obtained from all participants.</p></sec><sec sec-type="COI-statement" id="hsr270507-sec-0150"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec id="hsr270507-sec-0180"><title>Transparency Statement</title><p>The lead author Carina U. Persson affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.</p></sec></body><back><ack id="hsr270507-sec-0120"><title>Acknowledgments</title><p>The authors express their great gratitude to the individuals with COVID&#x02010;19 who participated in the GOT&#x02010;RECOV&#x02010;19 ICU study. Open access funding was provided by the University of Gothenburg.</p></ack><sec sec-type="data-availability" id="hsr270507-sec-0170"><title>Data Availability Statement</title><p>The dataset is available from the principal investigator Carina U Persson (<email>carina.persson@gu.se</email>) following a reasonable request. According to Swedish regulations, permission to use data can be obtained after an application to and approval by the Swedish Ethical Review Authority. The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.</p></sec><ref-list content-type="cited-references" id="hsr270507-bibl-0001"><title>References</title><ref id="hsr270507-bib-0001"><label>1</label><mixed-citation publication-type="miscellaneous" id="hsr270507-cit-0001">World Health Organization. Emergencies, <ext-link xlink:href="https://www.who.int/europe/emergencies/situations/covid-19" ext-link-type="uri">https://www.who.int/europe/emergencies/situations/covid-19</ext-link>, accessed Oct 30, 2023.</mixed-citation></ref><ref id="hsr270507-bib-0002"><label>2</label><mixed-citation publication-type="miscellaneous" id="hsr270507-cit-0002">World Health Organization. Delphi Consensus, accessed Oct 30, 2023, <ext-link xlink:href="https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1" ext-link-type="uri">https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1</ext-link>.</mixed-citation></ref><ref id="hsr270507-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="hsr270507-cit-0003">
<string-name>
<given-names>N.</given-names>
<surname>Hussain</surname>
</string-name>, <string-name>
<given-names>C. M.</given-names>
<surname>Samuelsson</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Drummond</surname>
</string-name>, and <string-name>
<given-names>C. U.</given-names>
<surname>Persson</surname>
</string-name>, &#x0201c;<article-title>Prevalence of Fatigue at One&#x02010;Year Follow&#x02010;Up From the Gothenburg Recovery and Rehabilitation After COVID&#x02010;19 and Intensive Care Unit Study</article-title>,&#x0201d; <source>Scientific Reports</source>
<volume>12</volume>, no. <issue>1</issue> (<year>2022</year>): <elocation-id>11501</elocation-id>, <pub-id pub-id-type="doi">10.1038/s41598-022-14787-6</pub-id>.<pub-id pub-id-type="pmid">35821226</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="hsr270507-cit-0004">
<string-name>
<given-names>I. M.</given-names>
<surname>Larsson</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Hultstr&#x000f6;m</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Lipcsey</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Frithiof</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Rubertsson</surname>
</string-name>, and <string-name>
<given-names>E.</given-names>
<surname>Wallin</surname>
</string-name>, &#x0201c;<article-title>Poor Long&#x02010;Term Recovery After Critical COVID&#x02010;19 During 12 Months Longitudinal Follow&#x02010;Up</article-title>,&#x0201d; <source>Intensive &#x00026; Critical Care Nursing</source>
<volume>74</volume> (<year>2023</year>): <elocation-id>103311</elocation-id>, <pub-id pub-id-type="doi">10.1016/j.iccn.2022.103311</pub-id>.<pub-id pub-id-type="pmid">36028412</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="hsr270507-cit-0005">
<string-name>
<given-names>S.</given-names>
<surname>Weihe</surname>
</string-name>, <string-name>
<given-names>C. B.</given-names>
<surname>Mortensen</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Haase</surname>
</string-name>, et al., &#x0201c;<article-title>Long&#x02010;Term Cognitive and Functional Status in Danish ICU Patients With COVID&#x02010;19</article-title>,&#x0201d; <source>Acta Anaesthesiologica Scandinavica</source>
<volume>66</volume>, no. <issue>8</issue> (<year>2022</year>): <fpage>978</fpage>&#x02013;<lpage>986</lpage>, <pub-id pub-id-type="doi">10.1111/aas.14108</pub-id>.<pub-id pub-id-type="pmid">35748019</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="hsr270507-cit-0006">
<string-name>
<given-names>L.</given-names>
<surname>Gamberini</surname>
</string-name>, <string-name>
<given-names>C. A.</given-names>
<surname>Mazzoli</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Prediletto</surname>
</string-name>, et al., &#x0201c;<article-title>Health&#x02010;Related Quality of Life Profiles, Trajectories, Persistent Symptoms and Pulmonary Function One Year After ICU Discharge in Invasively Ventilated COVID&#x02010;19 Patients, a Prospective Follow&#x02010;Up Study</article-title>,&#x0201d; <source>Respiratory Medicine</source>
<volume>189</volume> (<year>2021</year>): <elocation-id>106665</elocation-id>, <pub-id pub-id-type="doi">10.1016/j.rmed.2021.106665</pub-id>.<pub-id pub-id-type="pmid">34717097</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="hsr270507-cit-0007">
<string-name>
<given-names>S.</given-names>
<surname>Noureddine</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Roux&#x02010;Claud&#x000e9;</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Laurent</surname>
</string-name>, et al., &#x0201c;<article-title>Evaluation of Long&#x02010;Term Sequelae by Cardiopulmonary Exercise Testing 12 Months After Hospitalization for Severe COVID&#x02010;19</article-title>,&#x0201d; <source>BMC Pulmonary Medicine</source>
<volume>23</volume>, no. <issue>1</issue> (<year>2023</year>): <fpage>13</fpage>, <pub-id pub-id-type="doi">10.1186/s12890-023-02313-x</pub-id>.<pub-id pub-id-type="pmid">36635717</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="hsr270507-cit-0008">
<string-name>
<given-names>L. M.</given-names>
<surname>Kimmig</surname>
</string-name>, <string-name>
<given-names>Z. A.</given-names>
<surname>Rako</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Ziegler</surname>
</string-name>, et al., &#x0201c;<article-title>Long&#x02010;Term Comprehensive Cardiopulmonary Phenotyping of COVID&#x02010;19</article-title>,&#x0201d; <source>Respiratory Research</source>
<volume>23</volume>, no. <issue>1</issue> (<year>2022</year>): <fpage>263</fpage>, <pub-id pub-id-type="doi">10.1186/s12931-022-02173-9</pub-id>.<pub-id pub-id-type="pmid">36131349</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="hsr270507-cit-0009">
<string-name>
<given-names>C. M. H.</given-names>
<surname>Wiertz</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Hemmen</surname>
</string-name>, <string-name>
<given-names>S. J. S.</given-names>
<surname>Sep</surname>
</string-name>, et al., &#x0201c;<article-title>Life After COVID&#x02010;19: The Road From Intensive Care Back to Living &#x02010; A Prospective Cohort Study</article-title>,&#x0201d; <source>BMJ Open</source>
<volume>12</volume>, no. <issue>11</issue> (<year>2022</year>): <elocation-id>e062332</elocation-id>, <pub-id pub-id-type="doi">10.1136/bmjopen-2022-062332</pub-id>.</mixed-citation></ref><ref id="hsr270507-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="hsr270507-cit-0010">
<string-name>
<given-names>E.</given-names>
<surname>Garrigues</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Janvier</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Kherabi</surname>
</string-name>, et al., &#x0201c;<article-title>Post&#x02010;Discharge Persistent Symptoms and Health&#x02010;Related Quality of Life After Hospitalization for COVID&#x02010;19</article-title>,&#x0201d; <source>Journal of Infection</source>
<volume>81</volume>, no. <issue>6</issue> (<year>2020</year>): <fpage>e4</fpage>&#x02013;<lpage>e6</lpage>, <pub-id pub-id-type="doi">10.1016/j.jinf.2020.08.029</pub-id>.<pub-id pub-id-type="pmid">32853602</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="hsr270507-cit-0011">
<string-name>
<given-names>P.</given-names>
<surname>Malik</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Patel</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Pinto</surname>
</string-name>, et al., &#x0201c;<article-title>Post&#x02010;Acute COVID&#x02010;19 Syndrome (PCS) and Health&#x02010;Related Quality of Life (HRQoL)&#x02010;A Systematic Review and Meta&#x02010;Analysis</article-title>,&#x0201d; <source>Journal of Medical Virology</source>
<volume>94</volume>, no. <issue>1</issue> (<year>2022</year>): <fpage>253</fpage>&#x02013;<lpage>262</lpage>, <pub-id pub-id-type="doi">10.1002/jmv.27309</pub-id>.<pub-id pub-id-type="pmid">34463956</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="hsr270507-cit-0012">
<string-name>
<given-names>P.</given-names>
<surname>Halvorsen</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Hultstr&#x000f6;m</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>H&#x000e4;stbacka</surname>
</string-name>, et al., &#x0201c;<article-title>Health&#x02010;Related Quality of Life After Surviving Intensive Care for COVID&#x02010;19: A Prospective Multicenter Cohort Study</article-title>,&#x0201d; <source>Scientific Reports</source>
<volume>13</volume>, no. <issue>1</issue> (<year>2023</year>): <elocation-id>18035</elocation-id>, <pub-id pub-id-type="doi">10.1038/s41598-023-45346-2</pub-id>.<pub-id pub-id-type="pmid">37865685</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="hsr270507-cit-0013">
<string-name>
<given-names>L. E.</given-names>
<surname>Miller</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Bhattacharyya</surname>
</string-name>, and <string-name>
<given-names>A. L.</given-names>
<surname>Miller</surname>
</string-name>, &#x0201c;<article-title>Data Regarding Country&#x02010;Specific Variability in Covid&#x02010;19 Prevalence, Incidence, and Case Fatality Rate</article-title>,&#x0201d; <source>Data in Brief</source>
<volume>32</volume> (<year>2020</year>): <elocation-id>106276</elocation-id>, <pub-id pub-id-type="doi">10.1016/j.dib.2020.106276</pub-id>.<pub-id pub-id-type="pmid">32984469</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="hsr270507-cit-0014">
<string-name>
<given-names>M.</given-names>
<surname>Betschart</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Rezek</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Unger</surname>
</string-name>, et al., &#x0201c;<article-title>One Year Follow&#x02010;Up of Physical Performance and Quality of Life in Patients Surviving COVID&#x02010;19: A Prospective Cohort Study</article-title>,&#x0201d; <source>Swiss Medical Weekly</source>
<volume>151</volume> (<year>2021</year>): <elocation-id>w30072</elocation-id>, <pub-id pub-id-type="doi">10.4414/smw.2021.w30072</pub-id>.<pub-id pub-id-type="pmid">34751538</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="hsr270507-cit-0015">
<string-name>
<given-names>L.</given-names>
<surname>Carenzo</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Protti</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Dalla Corte</surname>
</string-name>, et al., &#x0201c;<article-title>Short&#x02010;Term Health&#x02010;Related Quality of Life, Physical Function and Psychological Consequences of Severe COVID&#x02010;19</article-title>,&#x0201d; <source>Annals of Intensive Care</source>
<volume>11</volume>, no. <issue>1</issue> (<year>2021</year>): <fpage>91</fpage>, <pub-id pub-id-type="doi">10.1186/s13613-021-00881-x</pub-id>.<pub-id pub-id-type="pmid">34089104</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="hsr270507-cit-0016">
<string-name>
<given-names>R. K.</given-names>
<surname>Lim</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Rosentreter</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Chen</surname>
</string-name>, et al., &#x0201c;<article-title>Quality of Life, Respiratory Symptoms, and Health Care Utilization 1 Year Following Outpatient Management of COVID&#x02010;19: A Prospective Cohort Study</article-title>,&#x0201d; <source>Scientific Reports</source>
<volume>12</volume>, no. <issue>1</issue> (<year>2022</year>): <elocation-id>12988</elocation-id>, <pub-id pub-id-type="doi">10.1038/s41598-022-17243-7</pub-id>.<pub-id pub-id-type="pmid">35906362</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="hsr270507-cit-0017">
<string-name>
<given-names>M.</given-names>
<surname>Moens</surname>
</string-name>, <string-name>
<given-names>R. V.</given-names>
<surname>Duarte</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>De Smedt</surname>
</string-name>, et al., &#x0201c;<article-title>Health&#x02010;Related Quality of Life in Persons Post&#x02010;COVID&#x02010;19 Infection in Comparison to Normative Controls and Chronic Pain Patients</article-title>,&#x0201d; <source>Frontiers in Public Health</source>
<volume>10</volume> (<year>2022</year>): <elocation-id>991572</elocation-id>, <pub-id pub-id-type="doi">10.3389/fpubh.2022.991572</pub-id>.<pub-id pub-id-type="pmid">36339175</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="hsr270507-cit-0018">
<string-name>
<given-names>L.</given-names>
<surname>Sigfrid</surname>
</string-name>, <string-name>
<given-names>T. M.</given-names>
<surname>Drake</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Pauley</surname>
</string-name>, et al., &#x0201c;<article-title>Long Covid in Adults Discharged From UK Hospitals After Covid&#x02010;19: A Prospective, Multicentre Cohort Study Using the ISARIC WHO Clinical Characterisation Protocol</article-title>,&#x0201d; <source>Lancet Regional Health &#x02010; Europe</source>
<volume>8</volume> (<year>2021</year>): <elocation-id>100186</elocation-id>, <pub-id pub-id-type="doi">10.1016/j.lanepe.2021.100186</pub-id>.<pub-id pub-id-type="pmid">34386785</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="hsr270507-cit-0019">
<string-name>
<given-names>M.</given-names>
<surname>Taboada</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Moreno</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Cari&#x000f1;ena</surname>
</string-name>, et al., &#x0201c;<article-title>Quality of Life, Functional Status, and Persistent Symptoms After Intensive Care of COVID&#x02010;19 Patients</article-title>,&#x0201d; <source>British Journal of Anaesthesia</source>
<volume>126</volume>, no. <issue>3</issue> (<year>2021</year>): <fpage>e110</fpage>&#x02013;<lpage>e113</lpage>, <pub-id pub-id-type="doi">10.1016/j.bja.2020.12.007</pub-id>.<pub-id pub-id-type="pmid">33413976</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="hsr270507-cit-0020">
<string-name>
<given-names>B. C.</given-names>
<surname>Todt</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Szlejf</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Duim</surname>
</string-name>, et al., &#x0201c;<article-title>Clinical Outcomes and Quality of Life of COVID&#x02010;19 Survivors: A Follow&#x02010;Up of 3 Months Post Hospital Discharge</article-title>,&#x0201d; <source>Respiratory Medicine</source>
<volume>184</volume> (<year>2021</year>): <elocation-id>106453</elocation-id>, <pub-id pub-id-type="doi">10.1016/j.rmed.2021.106453</pub-id>.<pub-id pub-id-type="pmid">34010740</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="hsr270507-cit-0021">
<string-name>
<given-names>L. F.</given-names>
<surname>Lorini</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Labanca</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Bugada</surname>
</string-name>, et al., &#x0201c;<article-title>One&#x02010;Year Survival and Quality of Life of First Wave COVID&#x02010;19 Invasively Ventilated Patients in Lombardy, Italy</article-title>,&#x0201d; <source>Minerva Respiratory Medicine</source>
<volume>63</volume>, no. <issue>2</issue> (<year>2024</year>): <fpage>49</fpage>&#x02013;<lpage>57</lpage>, <pub-id pub-id-type="doi">10.23736/S2784-8477.23.02085-5</pub-id>.</mixed-citation></ref><ref id="hsr270507-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="hsr270507-cit-0022">
<string-name>
<given-names>A.</given-names>
<surname>Demoule</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Morawiec</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Decavele</surname>
</string-name>, et al., &#x0201c;<article-title>Health&#x02010;Related Quality of Life of COVID&#x02010;19 Two and 12 Months After Intensive Care Unit Admission</article-title>,&#x0201d; <source>Annals of Intensive Care</source>
<volume>12</volume>, no. <issue>1</issue> (<year>2022</year>): <fpage>16</fpage>, <pub-id pub-id-type="doi">10.1186/s13613-022-00991-0</pub-id>.<pub-id pub-id-type="pmid">35184214</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="hsr270507-cit-0023">
<string-name>
<given-names>E.</given-names>
<surname>Caamano</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Velasco</surname>
</string-name>, <string-name>
<given-names>M. V.</given-names>
<surname>Garcia</surname>
</string-name>, et al., &#x0201c;<article-title>Prognostic Factors for Deterioration of Quality of Life One Year After Admission to ICU for Severe SARS&#x02010;COV2 Infection</article-title>,&#x0201d; <source>Quality of Life Research</source>
<volume>33</volume>, no. <issue>1</issue> (<year>2024</year>): <fpage>123</fpage>&#x02013;<lpage>132</lpage>, <pub-id pub-id-type="doi">10.1007/s11136-023-03503-0</pub-id>.<pub-id pub-id-type="pmid">37615735</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="hsr270507-cit-0024">
<string-name>
<given-names>V.</given-names>
<surname>Likhvantsev</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Landoni</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Kuzovlev</surname>
</string-name>, et al., &#x0201c;<article-title>One Year Health&#x02010;Related Quality of Life After Discharge: A Prospective Cohort Study Among COVID&#x02010;19 ICU Survivors</article-title>,&#x0201d; <source>Signa Vitae</source>
<volume>19</volume>, no. <issue>2</issue> (<year>2023</year>): <fpage>55</fpage>&#x02013;<lpage>65</lpage>, <pub-id pub-id-type="doi">10.22514/sv.2022.036</pub-id>.</mixed-citation></ref><ref id="hsr270507-bib-0025"><label>25</label><mixed-citation publication-type="miscellaneous" id="hsr270507-cit-0025">EuroQol. EQ&#x02010;5D, accessed Oct 28, 2023, <ext-link xlink:href="https://euroqol.org/" ext-link-type="uri">https://euroqol.org/</ext-link>.</mixed-citation></ref><ref id="hsr270507-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="hsr270507-cit-0026">
<string-name>
<given-names>S. A. M.</given-names>
<surname>Khalifa</surname>
</string-name>, <string-name>
<given-names>M. M.</given-names>
<surname>Swilam</surname>
</string-name>, <string-name>
<given-names>A. A. A.</given-names>
<surname>El&#x02010;Wahed</surname>
</string-name>, et al., &#x0201c;<article-title>Beyond the Pandemic: COVID&#x02010;19 Pandemic Changed the Face of Life</article-title>,&#x0201d; <source>International Journal of Environmental Research and Public Health</source>
<volume>18</volume>, no. <issue>11</issue> (<year>2021</year>): <elocation-id>5645</elocation-id>, <pub-id pub-id-type="doi">10.3390/ijerph18115645</pub-id>.<pub-id pub-id-type="pmid">34070448</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="hsr270507-cit-0027">
<string-name>
<given-names>L.</given-names>
<surname>Gamberini</surname>
</string-name>, <string-name>
<given-names>C. A.</given-names>
<surname>Mazzoli</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Sintonen</surname>
</string-name>, et al., &#x0201c;<article-title>Quality of Life of COVID&#x02010;19 Critically Ill Survivors After ICU Discharge: 90 Days Follow&#x02010;Up</article-title>,&#x0201d; <source>Quality of Life Research</source>
<volume>30</volume>, no. <issue>10</issue> (<year>2021</year>): <fpage>2805</fpage>&#x02013;<lpage>2817</lpage>, <pub-id pub-id-type="doi">10.1007/s11136-021-02865-7</pub-id>.<pub-id pub-id-type="pmid">33977415</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="hsr270507-cit-0028">
<string-name>
<given-names>N.</given-names>
<surname>Hussain</surname>
</string-name>, <string-name>
<given-names>P. O.</given-names>
<surname>Hansson</surname>
</string-name>, <string-name>
<given-names>C. M.</given-names>
<surname>Samuelsson</surname>
</string-name>, and <string-name>
<given-names>C. U.</given-names>
<surname>Persson</surname>
</string-name>, &#x0201c;<article-title>Function and Activity Capacity at 1 Year After the Admission to Intensive Care Unit for COVID&#x02010;19</article-title>,&#x0201d; <source>Clinical Rehabilitation</source>
<volume>38</volume> (<year>2024</year>): <elocation-id>2692155241262871</elocation-id>, <pub-id pub-id-type="doi">10.1177/02692155241262871</pub-id>.</mixed-citation></ref><ref id="hsr270507-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="hsr270507-cit-0029">
<string-name>
<given-names>N.</given-names>
<surname>Hussain</surname>
</string-name>, <string-name>
<given-names>C. M.</given-names>
<surname>Samuelsson</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Drummond</surname>
</string-name>, and <string-name>
<given-names>C. U.</given-names>
<surname>Persson</surname>
</string-name>, &#x0201c;<article-title>Prevalence of Symptoms of Anxiety and Depression One Year After Intensive Care Unit Admission for COVID&#x02010;19</article-title>,&#x0201d; <source>BMC Psychiatry</source>
<volume>24</volume>, no. <issue>1</issue> (<year>2024</year>): <fpage>170</fpage>, <pub-id pub-id-type="doi">10.1186/s12888-024-05603-8</pub-id>.<pub-id pub-id-type="pmid">38429751</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="hsr270507-cit-0030">
<string-name>
<given-names>E.</given-names>
<surname>von Elm</surname>
</string-name>, <string-name>
<given-names>D. G.</given-names>
<surname>Altman</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Egger</surname>
</string-name>, <string-name>
<given-names>S. J.</given-names>
<surname>Pocock</surname>
</string-name>, <string-name>
<given-names>P. C.</given-names>
<surname>G&#x000f8;tzsche</surname>
</string-name>, and <string-name>
<given-names>J. P.</given-names>
<surname>Vandenbroucke</surname>
</string-name>, &#x0201c;<article-title>The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies</article-title>,&#x0201d; <source>Journal of Clinical Epidemiology</source>
<volume>61</volume>, no. <issue>4</issue> (<year>2008</year>): <fpage>344</fpage>&#x02013;<lpage>349</lpage>, <pub-id pub-id-type="doi">10.1016/j.jclinepi.2007.11.008</pub-id>.<pub-id pub-id-type="pmid">18313558</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="hsr270507-cit-0031">
<collab collab-type="authors">The EuroQol Group</collab>
<article-title>EuroQol &#x02010; A New Facility for the Measurement of Health&#x02010;Related Quality of Life</article-title>,&#x0201d; <source>Health Policy</source>
<volume>16</volume>, no. <issue>3</issue> (<year>1990</year>): <fpage>199</fpage>&#x02013;<lpage>208</lpage>, <pub-id pub-id-type="doi">10.1016/0168-8510(90)90421-9</pub-id>.<pub-id pub-id-type="pmid">10109801</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0032"><label>32</label><mixed-citation publication-type="miscellaneous" id="hsr270507-cit-0032">EuroQol Research Foundation E&#x02010;D&#x02010;LU, 2018, accessed Oct 30, 2023, <ext-link xlink:href="https://euroqol.org/wp-content/uploads/2023/11/EQ-5D-3LUserguide-23-07.pdf" ext-link-type="uri">https://euroqol.org/wp-content/uploads/2023/11/EQ-5D-3LUserguide-23-07.pdf</ext-link>.</mixed-citation></ref><ref id="hsr270507-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="hsr270507-cit-0033">
<string-name>
<given-names>K.</given-names>
<surname>Burstr&#x000f6;m</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Sun</surname>
</string-name>, <string-name>
<given-names>U. G.</given-names>
<surname>Gerdtham</surname>
</string-name>, et al., &#x0201c;<article-title>Swedish Experience&#x02010;Based Value Sets for EQ&#x02010;5D Health States</article-title>,&#x0201d; <source>Quality of Life Research</source>
<volume>23</volume>, no. <issue>2</issue> (<year>2014</year>): <fpage>431</fpage>&#x02013;<lpage>442</lpage>, <pub-id pub-id-type="doi">10.1007/s11136-013-0496-4</pub-id>.<pub-id pub-id-type="pmid">23975375</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="hsr270507-cit-0034">
<string-name>
<given-names>A. F.</given-names>
<surname>Rousseau</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Minguet</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Colson</surname>
</string-name>, et al., &#x0201c;<article-title>Post&#x02010;Intensive Care Syndrome After a Critical COVID&#x02010;19: Cohort Study From a Belgian Follow&#x02010;Up Clinic</article-title>,&#x0201d; <source>Annals of Intensive Care</source>
<volume>11</volume>, no. <issue>1</issue> (<year>2021</year>): <fpage>118</fpage>, <pub-id pub-id-type="doi">10.1186/s13613-021-00910-9</pub-id>.<pub-id pub-id-type="pmid">34324073</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0035"><label>35</label><mixed-citation publication-type="book" id="hsr270507-cit-0035">
<string-name>
<given-names>W.</given-names>
<surname>Dw</surname>
</string-name>, <source>Biostatistics: Basic Concepts and Methodology for the Health Sciences edn. t, editor</source> (<publisher-name>Wiley</publisher-name>, <year>2010</year>), <fpage>539</fpage>&#x02013;<lpage>599</lpage>.</mixed-citation></ref><ref id="hsr270507-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="hsr270507-cit-0036">
<string-name>
<given-names>Y.</given-names>
<surname>Arabi</surname>
</string-name>, &#x0201c;<article-title>A Prospective Study of Prolonged Stay in the Intensive Care Unit: Predictors and Impact on Resource Utilization</article-title>,&#x0201d; <source>International Journal for Quality in Health Care</source>
<volume>14</volume>, no. <issue>5</issue> (<year>2002</year>): <fpage>403</fpage>&#x02013;<lpage>410</lpage>, <pub-id pub-id-type="doi">10.1093/intqhc/14.5.403</pub-id>.<pub-id pub-id-type="pmid">12389806</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="hsr270507-cit-0037">
<string-name>
<given-names>M.</given-names>
<surname>Segerdahl</surname>
</string-name>, <string-name>
<given-names>P. O.</given-names>
<surname>Hansson</surname>
</string-name>, <string-name>
<given-names>C. M.</given-names>
<surname>Samuelsson</surname>
</string-name>, and <string-name>
<given-names>C. U.</given-names>
<surname>Persson</surname>
</string-name>, &#x0201c;<article-title>Health&#x02010;Related Quality of Life in Stroke Survivors: A 5&#x02010;Year Follow&#x02010;Up of The Fall Study of Gothenburg (FallsGOT)</article-title>,&#x0201d; <source>BMC Geriatrics</source>
<volume>23</volume>, no. <issue>1</issue> (<year>2023</year>): <fpage>584</fpage>, <pub-id pub-id-type="doi">10.1186/s12877-023-04308-z</pub-id>.<pub-id pub-id-type="pmid">37736712</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="hsr270507-cit-0038">
<string-name>
<given-names>A. F.</given-names>
<surname>Rousseau</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Colson</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Minguet</surname>
</string-name>, et al., &#x0201c;<article-title>Characteristics of Mid&#x02010;Term Post&#x02010;Intensive Care Syndrome in Patients Attending a Follow&#x02010;Up Clinic: A Prospective Comparison Between COVID&#x02010;19 and Non&#x02010;COVID&#x02010;19 Survivors</article-title>,&#x0201d; <source>Critical Care Explorations</source>
<volume>5</volume>, no. <issue>1</issue> (<year>2023</year>): <elocation-id>e0850</elocation-id>, <pub-id pub-id-type="doi">10.1097/cce.0000000000000850</pub-id>.<pub-id pub-id-type="pmid">36699242</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="hsr270507-cit-0039">
<string-name>
<given-names>P.</given-names>
<surname>Balakumar</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Maung&#x02010;U</surname>
</string-name>, and <string-name>
<given-names>G.</given-names>
<surname>Jagadeesh</surname>
</string-name>, &#x0201c;<article-title>Prevalence and Prevention of Cardiovascular Disease and Diabetes Mellitus</article-title>,&#x0201d; <source>Pharmacological Research</source>
<volume>113</volume>, no. <issue>Pt A</issue> (<year>2016</year>): <fpage>600</fpage>&#x02013;<lpage>609</lpage>, <pub-id pub-id-type="doi">10.1016/j.phrs.2016.09.040</pub-id>.<pub-id pub-id-type="pmid">27697647</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="hsr270507-cit-0040">
<string-name>
<given-names>A. I.</given-names>
<surname>Vinik</surname>
</string-name>, <string-name>
<given-names>M. L.</given-names>
<surname>Nevoret</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Casellini</surname>
</string-name>, and <string-name>
<given-names>H.</given-names>
<surname>Parson</surname>
</string-name>, &#x0201c;<article-title>Diabetic Neuropathy</article-title>,&#x0201d; <source>Endocrinology and Metabolism Clinics of North America</source>
<volume>42</volume>, no. <issue>4</issue> (<year>2013</year>): <fpage>747</fpage>&#x02013;<lpage>787</lpage>, <pub-id pub-id-type="doi">10.1016/j.ecl.2013.06.001</pub-id>.<pub-id pub-id-type="pmid">24286949</pub-id>
</mixed-citation></ref><ref id="hsr270507-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="hsr270507-cit-0041">
<string-name>
<given-names>T. Y.</given-names>
<surname>Wong</surname>
</string-name>, <string-name>
<given-names>C. M.</given-names>
<surname>Cheung</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Larsen</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Sharma</surname>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>Sim&#x000f3;</surname>
</string-name>, &#x0201c;<article-title>Diabetic Retinopathy</article-title>,&#x0201d; <source>Nature Reviews Disease Primers</source>
<volume>2</volume> (<year>2016</year>): <elocation-id>16012</elocation-id>, <pub-id pub-id-type="doi">10.1038/nrdp.2016.12</pub-id>.</mixed-citation></ref><ref id="hsr270507-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="hsr270507-cit-0042">
<string-name>
<given-names>A.</given-names>
<surname>Lindahl</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Aro</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Reijula</surname>
</string-name>, et al., &#x0201c;<article-title>Women Report More Symptoms and Impaired Quality of Life: A Survey of Finnish COVID&#x02010;19 Survivors</article-title>,&#x0201d; <source>Infectious Diseases</source>
<volume>54</volume>, no. <issue>1</issue> (<year>2022</year>): <fpage>53</fpage>&#x02013;<lpage>62</lpage>, <pub-id pub-id-type="doi">10.1080/23744235.2021.1965210</pub-id>.<pub-id pub-id-type="pmid">34410220</pub-id>
</mixed-citation></ref></ref-list></back></article>